On Wednesday, January 24, the convertible loan note that the company offered closed. The offer was primarily directed to existing shareholders. The offering was oversubscribed to SEK 6,330,000, corresponding to 115% of the offer. The board has made the allocation decision and contract notes will be sent out during the day, today, Friday 26 January.
- It is both gratifying and a strength to be able to carry out an oversubscribed offering in this market, says CEO Henrik Båge in a comment.
The board is now evaluating the possibilities to be able to offer even those who did not receive an allocation the opportunity to subscribe to a second convertible offer on equivalent terms. Innformation on that will come shortly.
For more information, contact the company at ir@phoenixbiopower.com or by phone at 08-663 58 00.
